Antibacterial resistance in Streptococcus pyogenes (GAS) from healthy carriers and tonsillitis patients and association with antibacterial sale in the Faroe Islands.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
CitationAntibacterial resistance in Streptococcus pyogenes (GAS) from healthy carriers and tonsillitis patients and association with antibacterial sale in the Faroe Islands. 2016, 124 (4):327-32 APMIS
AbstractThe aim of this study was to investigate the antibacterial resistance of Streptococcus pyogenes (GAS), and correlate the findings with the sales of erythromycin and tetracycline. General practitioners in the Faroe Islands were recruited to send oropharyngeal swabs. From an ongoing pneumococcal study, nasopharyngeal swabs were sampled from healthy children 0-7 years of age. Erythromycin susceptibility data from Iceland were obtained from the reference laboratory at the Landspitali University Hospital. Susceptibility testing in the Faroe Islands and Iceland was performed according to CLSI methods and criteria. The resistance rate to erythromycin and tetracycline found in patients in the Faroe Islands in 2009/2010 was 6% and 30% respectively. Tetracycline resistance in patients declined significantly from 2009 to 2010 (37-10%, p-value = 0.006 < 0.05) and differed significantly between age groups (p-value = 0.03 < 0.05). In Iceland, there was a peak in erythromycin resistance in 2008 (44%) and a substantial decrease in 2009 (5%). Although the prevalence of erythromycin and tetracycline resistance in the Faroe Islands and Iceland may be associated with antimicrobial use, sudden changes can occur with the introduction of new resistant clones.
DescriptionTo access publisher's full text version of this article click on the hyperlink at the bottom of the page
RightsArchived with thanks to APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
- What causes decreased erythromycin resistance in Streptococcus pyogenes? Dynamics of four clones in a southern European region from 2005 to 2012.
- Authors: Montes M, Tamayo E, Mojica C, García-Arenzana JM, Esnal O, Pérez-Trallero E
- Issue date: 2014 Jun
- Susceptibility of Group A Streptococcus to Antimicrobial Agents in Northern Israel: A Surveillance Study.
- Authors: Chazan B, Raz R, Edelstein H, Kennes Y, Gal V, Colodner R
- Issue date: 2015 Oct
- Antibacterial Susceptibilities of Escherichia coli from Community-Acquired Urinary Tract Infections in the Faroe Islands, Associations with Antibacterial Sales, and Comparison with Iceland and Denmark.
- Authors: Magnussen MD, Gislason H, Gaini S, Kristinsson KG
- Issue date: 2018 Jan/Feb
- High incidence of erythromycin-resistant Streptococcus pyogenes in Monza (North Italy) in untreated children with symptoms of acute pharyngo-tonsillitis: an epidemiological and molecular study.
- Authors: Cocuzza CE, Mattina R, Mazzariol A, Orefici G, Rescaldani R, Primavera A, Bramati S, Masera G, Parizzi F, Cornaglia G, Fontana R
- Issue date: 1997 Winter
- Molecular epidemiology, antimicrobial susceptibilities and resistance mechanisms of Streptococcus pyogenes isolates resistant to erythromycin and tetracycline in Spain (1994-2006).
- Authors: Rubio-López V, Valdezate S, Alvarez D, Villalón P, Medina MJ, Salcedo C, Sáez-Nieto JA
- Issue date: 2012 Sep 21